Kobari M, Matsuno S
First Department of Surgery, Tohoku University School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai 980-77, Japan.
J Hepatobiliary Pancreat Surg. 1998;5(2):121-7. doi: 10.1007/s005340050021.
Differences between the clinical staging system of the Japan Pancreas Society (JPS) and the Union Internationale Contre le Cancer (UICC) stage classification may account for reported differences in the prognosis of pancreatic carcinoma between Japan and the West. In the review, we compared the characteristics of the JPS and UICC staging in 1689 patients, registered with the JPS from 1981 to 1990, who underwent resection for carcinoma of the pancreatic head. The survival rates correlated well with the JPS stage classification. The UICC staging did not reflect differences in prognoses among the stages. The current JPS staging system, introduced in 1993, still differs from that of the UICC. To compare the results of treatment for patients with pancreatic cancer it is important to establish a more practical and universal staging system for carcinoma of the pancreas.
日本胰腺学会（JPS）的临床分期系统与国际抗癌联盟（UICC）的分期分类之间的差异，可能是日本和西方报道的胰腺癌预后差异的原因。在这项综述中，我们比较了1981年至1990年在JPS登记的1689例接受胰头癌切除术患者的JPS和UICC分期特征。生存率与JPS分期分类密切相关。UICC分期并未反映各阶段之间的预后差异。1993年引入的现行JPS分期系统仍与UICC的不同。为了比较胰腺癌患者的治疗结果，建立一个更实用、更通用的胰腺癌分期系统很重要。
